Nourishing innovation

The first hyaluronic acid matrix

ingredient for skin & beauty

Ready to help consumers rewrite their skincare routine?

Increase skin ‘glow’ by 33%1

Boost skin hydration by 13%1

Reduce wrinkle formation1

Meet Dermial® – the skincare secret that your nutricosmetics portfolio has been waiting for. Clinical trial results demonstrate that at just 60 mg/day, our hyaluronic acid (HA) matrix ingredient works from within to deliver hydration, smoother skin and a healthy glow that consumers can see and feel.

Illuminating the science-backed benefits of Dermial® 

Through the synergistic effect of its naturally-occurring components – hyaluronic acid, glycosaminoglycans and 

hydrolysed collagen – Dermial® brings powerful nourishing and moisturising properties for skin health. Explore cutting-edge research behind Dermial®, including its unique ‘glow’ effect. 

Get underneath the skin of Dermial®

Science backed

Endorsed by

scientific studies.

Superior effect to fermentation-origin HA2

Thanks to the synergistic effect of its components.

Solid regulatory framework

Includes Novel Food (EU Commission) and GRAS status (FDA).

Easy to formulate

Only 60 mg/day dosage and excellent organoleptic properties.

Productinformation sheet

Talk to one of our experts

Ready to explore a new era of possibilities with a hyaluronic acid matrix ingredient? Discover how Dermial® can support your next innovation in the skin and beauty market with our product information sheet.

Our experts are always on hand if you have any questions about our products. Fill out our contact form and someone will be in touch as soon as possible.

1 Gálvez-Martín P et al. Evaluating the safety and efficacy of a novel hyaluronic acid matrix ingredient, for skincare: A randomized double-blind placebo-controlled trial. Journal of Investigative Dermatology, vol. 144 (8), S50, 2024.


2 Galvez-Martin P et al. Comparative in vitro efficacy of a hyaluronic acid (HA) matrix ingredient containing HA, dermatan sulphate and collagen (Dermial®) versus pure HA from extraction or fermentation origin. The FASEB Journal, 2022, vol. 36, R3806.

Connect with us

© 2026. Bioiberica S.A.U. All rights reserved.

These statements have not been evaluated by the Food and Drug Administration or other competent food authorities. The product is not intended to diagnose, treat, cure, or prevent any disease. This information is only for business-to business use and not meant to be addressed to final consumers. Therefore, Bioiberica assumes no liability for the statements that the producer of the final product may include in its own publicity to consumers.